UTAH MEDICAL PRODUCTS INC Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Utah Medical Products Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Utah Medical Products Inc Debt-to-equity for the quarter ending September 30, 2024 was 5.22 %, a 30% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 5.22 -2.24 -30% Sep 30, 2024
Q2 2024 5.63 -2.66 -32.1% Jun 30, 2024
Q1 2024 6.2 -2.34 -27.4% Mar 31, 2024
Q4 2023 6.74 -2.18 -24.4% Dec 31, 2023
Q3 2023 7.46 -1.35 -15.3% Sep 30, 2023
Q2 2023 8.29 -0.38 -4.39% Jun 30, 2023
Q1 2023 8.55 -0.29 -3.28% Mar 31, 2023
Q4 2022 8.92 +0.25 +2.89% Dec 31, 2022
Q3 2022 8.81 -0.05 -0.57% Sep 30, 2022
Q2 2022 8.66 -0.17 -1.93% Jun 30, 2022
Q1 2022 8.84 +0.04 +0.45% Mar 31, 2022
Q4 2021 8.66 -0.2 -2.26% Dec 31, 2021
Q3 2021 8.85 +0.01 +0.11% Sep 30, 2021
Q2 2021 8.83 -0.21 -2.32% Jun 30, 2021
Q1 2021 8.8 -0.58 -6.18% Mar 31, 2021
Q4 2020 8.86 -1.64 -15.6% Dec 31, 2020
Q3 2020 8.84 -2.56 -22.4% Sep 30, 2020
Q2 2020 9.04 -2.89 -24.2% Jun 30, 2020
Q1 2020 9.38 -4.11 -30.5% Mar 31, 2020
Q4 2019 10.5 -3.83 -26.7% Dec 31, 2019
Q3 2019 11.4 -4.55 -28.5% Sep 30, 2019
Q2 2019 11.9 -4.14 -25.8% Jun 30, 2019
Q1 2019 13.5 -1.33 -8.98% Mar 31, 2019
Q4 2018 14.3 +0.61 +4.45% Dec 31, 2018
Q3 2018 16 +4.38 +37.8% Sep 30, 2018
Q2 2018 16.1 +3.93 +32.4% Jun 30, 2018
Q1 2018 14.8 +1.96 +15.3% Mar 31, 2018
Q4 2017 13.7 +0.16 +1.18% Dec 31, 2017
Q3 2017 11.6 -2.88 -19.9% Sep 30, 2017
Q2 2017 12.1 -3.13 -20.5% Jun 30, 2017
Q1 2017 12.9 -3.21 -20% Mar 31, 2017
Q4 2016 13.6 -2.95 -17.9% Dec 31, 2016
Q3 2016 14.5 -5.02 -25.8% Sep 30, 2016
Q2 2016 15.3 -6.92 -31.2% Jun 30, 2016
Q1 2016 16.1 -9.35 -36.8% Mar 31, 2016
Q4 2015 16.5 -12.3 -42.6% Dec 31, 2015
Q3 2015 19.5 -11.2 -36.5% Sep 30, 2015
Q2 2015 22.2 -11.6 -34.3% Jun 30, 2015
Q1 2015 25.4 -12.1 -32.2% Mar 31, 2015
Q4 2014 28.8 -13.3 -31.7% Dec 31, 2014
Q3 2014 30.7 -16.1 -34.5% Sep 30, 2014
Q2 2014 33.8 -18.2 -35% Jun 30, 2014
Q1 2014 37.5 -20.2 -35% Mar 31, 2014
Q4 2013 42.1 -22.6 -34.9% Dec 31, 2013
Q3 2013 46.8 -27 -36.6% Sep 30, 2013
Q2 2013 52 -30.5 -37% Jun 30, 2013
Q1 2013 57.7 -33.2 -36.5% Mar 31, 2013
Q4 2012 64.7 Dec 31, 2012
Q3 2012 73.8 Sep 30, 2012
Q2 2012 82.4 Jun 30, 2012
Q1 2012 90.9 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.